According to a new feature by the Washington Post, approximately 16 million American adults are on GLP-1 drugs such as ...

Innovent Biologics, the first Chinese company to win regulatory approval to sell a GLP-1 drug for weight loss and diabetes, ...

A pharmacist holds boxes of Ozempic, a semaglutide injection drug made by Novo Nordisk, in Provo, Utah, on March 29, 2023.

The proposed premium increases would average 16.8% for individuals policies, including those sold on the Healthcare.gov website, which some call "Obamacare." That is a bigger request than last year's ...